Cas no 1001499-90-6 (methyl 1-(4-chloro-3,5-dimethyl-1H-pyrazol-1-yl)methyl-1H-pyrazole-3-carboxylate)
methyl 1-(4-chloro-3,5-dimethyl-1H-pyrazol-1-yl)methyl-1H-pyrazole-3-carboxylate Chemical and Physical Properties
Names and Identifiers
-
- <br>1-(4-Chloro-3,5-dimethyl-pyrazol-1-ylmethyl)-1 H -pyrazole-3-carboxylic aci d methyl ester
- AKOS B018607
- ART-CHEM-BB B018607
- 1-(4-CHLORO-3,5-DIMETHYL-PYRAZOL-1-YLMETHYL)-1 H-PYRAZOLE-3-CARBOXYLIC ACID METHYL ESTER
- methyl 1-(4-chloro-3,5-dimethyl-1H-pyrazol-1-yl)methyl-1H-pyrazole-3-carboxylate
- 1001499-90-6
- Methyl1-((4-chloro-3,5-dimethyl-1H-pyrazol-1-yl)methyl)-1H-pyrazole-3-carboxylate
- AKOS000307879
- DTXSID901131023
- 1-(4-Chloro-3,5-dimethyl-pyrazol-1-ylmethyl)-1H-pyrazole-3-carboxylic acid methyl ester
- methyl 1-[(4-chloro-3,5-dimethyl-1H-pyrazol-1-yl)methyl]-1H-pyrazole-3-carboxylate
- methyl 1-[(4-chloro-3,5-dimethylpyrazol-1-yl)methyl]pyrazole-3-carboxylate
- BBL039056
- STK312927
- CS-0282803
- EN300-229334
- Methyl 1-((4-chloro-3,5-dimethyl-1H-pyrazol-1-yl)methyl)-1H-pyrazole-3-carboxylate
-
- MDL: MFCD04969139
- Inchi: 1S/C11H13ClN4O2/c1-7-10(12)8(2)16(13-7)6-15-5-4-9(14-15)11(17)18-3/h4-5H,6H2,1-3H3
- InChI Key: TVOFRCQCJUVYHJ-UHFFFAOYSA-N
- SMILES: ClC1C(C)=NN(C=1C)CN1C=CC(C(=O)OC)=N1
Computed Properties
- Exact Mass: 268.0727034Da
- Monoisotopic Mass: 268.0727034Da
- Isotope Atom Count: 0
- Hydrogen Bond Donor Count: 0
- Hydrogen Bond Acceptor Count: 6
- Heavy Atom Count: 18
- Rotatable Bond Count: 4
- Complexity: 317
- Covalently-Bonded Unit Count: 1
- Defined Atom Stereocenter Count: 0
- Undefined Atom Stereocenter Count : 0
- Defined Bond Stereocenter Count: 0
- Undefined Bond Stereocenter Count: 0
- XLogP3: 2
- Topological Polar Surface Area: 61.9?2
Experimental Properties
- Density: 1.4±0.1 g/cm3
- Boiling Point: 410.2±45.0 °C at 760 mmHg
- Flash Point: 201.9±28.7 °C
- Vapor Pressure: 0.0±1.0 mmHg at 25°C
methyl 1-(4-chloro-3,5-dimethyl-1H-pyrazol-1-yl)methyl-1H-pyrazole-3-carboxylate Security Information
- Signal Word:warning
- Hazard Statement: H303May be harmful if swallowed+H313Skin contact may be harmful+H333Inhalation may be harmful to the body
- Warning Statement: P264+P280+P305+P351+P338+P337+P313
- Safety Instruction: H303+H313+H333
- Storage Condition:storage at -4℃ (1-2weeks), longer storage period at -20℃ (1-2years)
methyl 1-(4-chloro-3,5-dimethyl-1H-pyrazol-1-yl)methyl-1H-pyrazole-3-carboxylate Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| Fluorochem | 027121-250mg |
1-(4-Chloro-3,5-dimethyl-pyrazol-1-ylmethyl)-1 H -pyrazole-3-carboxylic acid methyl ester |
1001499-90-6 | 250mg |
£182.00 | 2022-03-01 | ||
| Fluorochem | 027121-1g |
1-(4-Chloro-3,5-dimethyl-pyrazol-1-ylmethyl)-1 H -pyrazole-3-carboxylic acid methyl ester |
1001499-90-6 | 1g |
£363.00 | 2022-03-01 | ||
| Fluorochem | 027121-5g |
1-(4-Chloro-3,5-dimethyl-pyrazol-1-ylmethyl)-1 H -pyrazole-3-carboxylic acid methyl ester |
1001499-90-6 | 5g |
£963.00 | 2022-03-01 | ||
| Ambeed | A401274-1g |
Methyl 1-((4-chloro-3,5-dimethyl-1H-pyrazol-1-yl)methyl)-1H-pyrazole-3-carboxylate |
1001499-90-6 | 97% | 1g |
$445.0 | 2024-08-02 | |
| Chemenu | CM483013-1g |
Methyl 1-((4-chloro-3,5-dimethyl-1H-pyrazol-1-yl)methyl)-1H-pyrazole-3-carboxylate |
1001499-90-6 | 97% | 1g |
$731 | 2022-06-14 | |
| Enamine | EN300-229334-0.05g |
methyl 1-[(4-chloro-3,5-dimethyl-1H-pyrazol-1-yl)methyl]-1H-pyrazole-3-carboxylate |
1001499-90-6 | 95% | 0.05g |
$88.0 | 2024-06-20 | |
| Enamine | EN300-229334-0.1g |
methyl 1-[(4-chloro-3,5-dimethyl-1H-pyrazol-1-yl)methyl]-1H-pyrazole-3-carboxylate |
1001499-90-6 | 95% | 0.1g |
$132.0 | 2024-06-20 | |
| Enamine | EN300-229334-0.25g |
methyl 1-[(4-chloro-3,5-dimethyl-1H-pyrazol-1-yl)methyl]-1H-pyrazole-3-carboxylate |
1001499-90-6 | 95% | 0.25g |
$188.0 | 2024-06-20 | |
| Enamine | EN300-229334-0.5g |
methyl 1-[(4-chloro-3,5-dimethyl-1H-pyrazol-1-yl)methyl]-1H-pyrazole-3-carboxylate |
1001499-90-6 | 95% | 0.5g |
$353.0 | 2024-06-20 | |
| Enamine | EN300-229334-1.0g |
methyl 1-[(4-chloro-3,5-dimethyl-1H-pyrazol-1-yl)methyl]-1H-pyrazole-3-carboxylate |
1001499-90-6 | 95% | 1.0g |
$470.0 | 2024-06-20 |
methyl 1-(4-chloro-3,5-dimethyl-1H-pyrazol-1-yl)methyl-1H-pyrazole-3-carboxylate Related Literature
-
Huading Zhang,Lee R. Moore,Maciej Zborowski,P. Stephen Williams,Shlomo Margel,Jeffrey J. Chalmers Analyst, 2005,130, 514-527
-
Daniel Messmer,Stefan Salentinig,Jakob Heier Nanoscale, 2019,11, 6929-6938
-
Aloke Das,K. K. Mahato,Chayan K. Nandi,Tapas Chakraborty,Shridhar R. Gadre,Nikhil A. Gokhale Phys. Chem. Chem. Phys., 2002,4, 2162-2168
-
Weili Dai,Guangjun Wu,Michael Hunger Chem. Commun., 2015,51, 13779-13782
-
Amit Kumar Majhi,Subbarao Kanchi,V. Venkataraman,K. G. Ayappa,Prabal K. Maiti Soft Matter, 2015,11, 8632-8640
Additional information on methyl 1-(4-chloro-3,5-dimethyl-1H-pyrazol-1-yl)methyl-1H-pyrazole-3-carboxylate
Methyl 1-(4-chloro-3,5-dimethyl-1H-pyrazol-1-yl)methyl-1H-pyrazole-3-carboxylate: A Comprehensive Overview
Methyl 1-(4-chloro-3,5-dimethyl-1H-pyrazol-1-yl)methyl-1H-pyrazole-3-carboxylate (CAS No. 1001499-90-6) is a specialized organic compound that has garnered significant attention in the field of pharmaceutical chemistry and bioorganic synthesis. This compound, characterized by its intricate molecular structure, holds promise in various applications, particularly in the development of novel therapeutic agents and biochemical research tools. Its unique chemical properties and potential biological activities make it a subject of extensive interest among researchers.
The molecular framework of Methyl 1-(4-chloro-3,5-dimethyl-1H-pyrazol-1-yl)methyl-1H-pyrazole-3-carboxylate consists of multiple heterocyclic rings, including a pyrazole core substituted with chloro and methyl groups. This structural configuration imparts distinct electronic and steric properties, which are crucial for its interaction with biological targets. The presence of the chloro substituent at the 4-position of the pyrazole ring enhances its reactivity, making it a valuable intermediate in synthetic chemistry.
In recent years, there has been a surge in research focused on developing small molecules with pyrazole derivatives due to their diverse pharmacological properties. Pyrazole-based compounds have been extensively studied for their potential applications in treating various diseases, including cancer, inflammation, and infectious disorders. The specific substitution pattern in Methyl 1-(4-chloro-3,5-dimethyl-1H-pyrazol-1-yl)methyl-1H-pyrazole-3-carboxylate makes it an intriguing candidate for further exploration in drug discovery.
One of the most compelling aspects of this compound is its role as a building block in the synthesis of more complex molecules. The carboxylate group at the 3-position of the pyrazole ring provides a versatile handle for further functionalization, allowing chemists to design novel analogs with tailored biological activities. This flexibility has made Methyl 1-(4-chloro-3,5-dimethyl-1H-pyrazol-1-yl)methyl-1H-pyrazole-3-carboxylate a valuable asset in medicinal chemistry libraries.
Recent studies have highlighted the potential of chlorinated pyrazole derivatives as kinase inhibitors. Kinases are enzymes that play a critical role in many cellular processes, and their dysregulation is often associated with diseases such as cancer. The chloro substituent in Methyl 1-(4-chloro-3,5-dimethyl-1H-pyrazol-1-yl)methyl-1H-pyrazole-3-carboxylate is believed to enhance its binding affinity to kinase active sites, making it a promising lead compound for developing targeted therapies.
The synthesis of Methyl 1-(4-chloro-3,5-dimethyl-1H-pyrazol-1-yl)methyl-1H-pyrazole-3-carboxylate involves multi-step organic transformations that showcase the expertise of synthetic chemists. The process typically begins with the preparation of a halogenated pyrazole precursor, followed by functional group interconversions to introduce the desired substituents. The use of palladium-catalyzed cross-coupling reactions has been particularly effective in constructing the complex heterocyclic core of this compound.
The biological evaluation of Methyl 1-(4-chloro-3,5-dimethyl-1H-pyrazol-1-ylmethyl)- has revealed several interesting findings. In vitro assays have demonstrated its ability to inhibit the growth of certain cancer cell lines by modulating key signaling pathways. Additionally, preliminary studies suggest that this compound may exhibit anti-inflammatory properties by interacting with specific transcription factors involved in inflammation regulation.
The structural diversity offered by Methyl 1-(4-chloro
The pharmaceutical industry has shown considerable interest in exploring novel derivatives of pyrazole-based compounds due to their favorable pharmacokinetic profiles and low toxicity. The synthetic accessibility of Methyl
In conclusion, Methyl
1001499-90-6 (methyl 1-(4-chloro-3,5-dimethyl-1H-pyrazol-1-yl)methyl-1H-pyrazole-3-carboxylate) Related Products
- 119169-63-0(Ethyl 4-chloro-1,3-dimethyl-1H-pyrazole-5-carboxylate)
- 514800-80-7(4-Chloro-1,5-dimethyl-1H-pyrazole-3-carboxylic acid)
- 400877-54-5(methyl 4-chloro-1-methyl-1H-pyrazole-5-carboxylate)
- 512809-96-0(ethyl 4-chloro-1,5-dimethyl-1H-pyrazole-3-carboxylate)
- 942853-19-2(ethyl 4-chloro-1-methyl-1H-pyrazole-3-carboxylate)
- 1004192-86-2(1-(3,5-dimethyl-1H-pyrazol-1-yl)methyl-1H-pyrazole-3-carboxylic acid)
- 1004192-90-8(1-(4-chloro-3,5-dimethyl-1H-pyrazol-1-yl)methyl-1H-pyrazole-3-carboxylic acid)
- 1006473-16-0(1-(4-chloro-1H-pyrazol-1-yl)methyl-1H-pyrazole-3-carboxylic acid)
- 1006341-09-8(4-Chloro-1-([5-methyl-3-(trifluoromethyl)-1H-pyrazol-1-yl]methyl)-1H-pyrazole-3-carboxylic acid)
- 400877-55-6(ethyl 4-chloro-1-methyl-1H-pyrazole-5-carboxylate)